Follow
Latha Velayudhan
Latha Velayudhan
University of Leicester
No verified email
Title
Cited by
Cited by
Year
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease
DP Wightman, IE Jansen, JE Savage, AA Shadrin, S Bahrami, D Holland, ...
Nature genetics 53 (9), 1276-1282, 2021
5122021
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ...
Archives of general psychiatry 67 (7), 739-748, 2010
4852010
Review of brief cognitive tests for patients with suspected dementia
L Velayudhan, SH Ryu, M Raczek, M Philpot, J Lindesay, M Critchfield, ...
International psychogeriatrics 26 (8), 1247-1262, 2014
2842014
A multicentre validation study of the diagnostic value of plasma neurofilament light
NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ...
Nature communications 12 (1), 3400, 2021
2722021
Risk of developing dementia in people with diabetes and mild cognitive impairment
L Velayudhan, M Poppe, N Archer, P Proitsi, RG Brown, S Lovestone
The British Journal of Psychiatry 196 (1), 36-40, 2010
1882010
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
P Proitsi, M Kim, L Whiley, A Simmons, M Sattlecker, L Velayudhan, ...
Alzheimer's & Dementia 13 (2), 140-151, 2017
1852017
A feasibility and tolerability study of lithium in Alzheimer's disease
A Macdonald, K Briggs, M Poppe, A Higgins, L Velayudhan, S Lovestone
International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2008
1842008
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease
L Velayudhan, P Proitsi, E Westman, JS Muehlboeck, P Mecocci, B Vellas, ...
Journal of Alzheimer's Disease 33 (3), 755-766, 2013
1602013
Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of …
K Bakrania, CL Edwardson, DH Bodicoat, DW Esliger, JMR Gill, A Kazi, ...
BMC public health 16, 1-10, 2015
1302015
Plasma transthyretin as a candidate marker for Alzheimer's disease
L Velayudhan, R Killick, A Hye, A Kinsey, A Güntert, S Lynham, M Ward, ...
Journal of Alzheimer's Disease 28 (2), 369-375, 2012
1142012
Neuropsychiatric symptoms in mild cognitive impairment: a literature review
E Martin, L Velayudhan
Dementia and Geriatric Cognitive Disorders 49 (2), 146-155, 2020
1092020
Smell identification function as a severity and progression marker in Alzheimer's disease
L Velayudhan, M Pritchard, JF Powell, P Proitsi, S Lovestone
International psychogeriatrics 25 (7), 1157-1166, 2013
992013
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis
P Proitsi, MK Lupton, L Velayudhan, S Newhouse, I Fogh, M Tsolaki, ...
PLoS medicine 11 (9), e1001713, 2014
942014
Neurological soft signs in never‐treated schizophrenia
G Venkatasubramanian, V Latha, BN Gangadhar, N Janakiramaiah, ...
Acta Psychiatrica Scandinavica 108 (2), 144-146, 2003
912003
Association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer’s disease
M Kim, A Nevado-Holgado, L Whiley, SG Snowden, H Soininen, ...
Journal of Alzheimer's Disease 60 (3), 809-817, 2017
792017
Smell identification function and Alzheimer's disease: a selective review
L Velayudhan
Current opinion in psychiatry 28 (2), 173-179, 2015
742015
Metabolic effects of breaking prolonged sitting with standing or light walking in older South Asians and White Europeans: a randomized acute study
T Yates, CL Edwardson, C Celis-Morales, SJH Biddle, D Bodicoat, ...
The Journals of Gerontology: Series A 75 (1), 139-146, 2020
722020
Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review
L Velayudhan, E Van Diepen, M Marudkar, O Hands, S Suribhatla, ...
Current pharmaceutical design 20 (13), 2218-2230, 2014
702014
Mental health of people living with dementia in care homes during COVID-19 pandemic
L Velayudhan, D Aarsland, C Ballard
International Psychogeriatrics 32 (10), 1253-1254, 2020
652020
Assessment and management of neuropsychiatric symptoms in Parkinson’s disease
C Mueller, AP Rajkumar, YM Wan, L Velayudhan, D Ffytche, ...
CNS drugs 32 (7), 621-635, 2018
652018
The system can't perform the operation now. Try again later.
Articles 1–20